Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Role of T-cells in immunotherapy of pancreatic and colon cancers
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Role of T-cells in immunotherapy of pancreatic and colon cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pancreatic Cancer
100%
T Cells
100%
Colon Cancer
100%
Gastrointestinal Tumours
100%
CAR T-cell Therapy
100%
Immune System
50%
Chemotherapy
50%
Adverse Effects
50%
Radiation Therapy
50%
Tumor
50%
Surgical Procedures
50%
Early Identification
50%
Clinical Research
50%
Treatment Effect
50%
Quality of Life
50%
Tumor Microenvironment
50%
Cancer Mortality
50%
Cancer Cells
50%
Treatment Modalities
50%
Advanced Stage
50%
Tumor Location
50%
Patient Outcomes
50%
Ongoing Clinical Trials
50%
Targeted Therapy
50%
Gastrointestinal Cancer
50%
Oncologic
50%
Early Management
50%
Resistance to Treatment
50%
Hybrid Antigen
50%
Targeted Immunotherapy
50%
Toxicity Control
50%
Major Cancers
50%
Patient Quality of Life
50%
Medicine and Dentistry
T Cell
100%
Immunotherapy
100%
Pancreas Cancer
100%
Colon Carcinoma
100%
Malignant Neoplasm
66%
Quality of Life
66%
Antigen
66%
CAR T-cell therapy
66%
Gastrointestinal Tumor
66%
Adverse Event
33%
Clinical Trial
33%
Surgical Technique
33%
Cancer Cell
33%
Clinical Research
33%
Tumor Microenvironment
33%
Immune System
33%
Treatment Effect
33%
Targeted Therapy
33%
Specific Tumor
33%
Gastrointestinal Cancer
33%
Chemotherapy
33%
Radiation Therapy
33%
Tumor
33%
Treatment Modality
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Pancreas Cancer
100%
Immunotherapy
100%
Colon Carcinoma
100%
Antigen
66%
Gastrointestinal Tumor
66%
CAR T-Cell Therapy
66%
Adverse Event
33%
Neoplasm
33%
Clinical Trial
33%
Clinical Research
33%
Chemotherapy Regimens
33%
Digestive System Cancer
33%
Tumor Microenvironment
33%
Nursing and Health Professions
Chimeric Antigen Receptor T-Cell
66%
Cell Therapy
66%
Gastrointestinal Tumor
66%
Digestive System Cancer
33%